All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Wegovy Results After 3 Weeks: What to Expect

Wegovy results after 3 weeks at 0.25 mg. Covers the steady-state plateau, weight expectations, appetite status, and exactly how to prepare for the 0.5...

By FormBlends Editorial Research||
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Key Takeaway

See your GLP-1 options in about 2 minutes. Free and private. See my options →

Wegovy results after 3 weeks at 0.25 mg. Covers the steady-state plateau, weight expectations, appetite status, and exactly how to prepare for the 0.5 mg dose increase.

Wegovy results after 3 weeks confirm that your body has accepted semaglutide. You have taken three injections at 0.25 mg, reached near-steady-state blood levels, and established a baseline for how this medication affects your appetite and digestion. The scale may show a modest drop of 1 to 5 pounds. Most you're one week away from your first dose increase to 0.5 mg, where the weight loss process truly begins.

The 3-Week Milestone

Here is where most patients stand after 3 weeks on Wegovy:

AreaTypical Status at Week 3
Weight loss1-5 lbs total (0.5-2% of starting weight)
AppetiteMildly reduced. new eating patterns established
Side effectsResolved for 90%+ of patients
Injection routineComfortable and automatic
EnergyNormal or slightly improved
CravingsReduced in many patients, especially for processed/sweet foods

Putting Week 3 in the Full Timeline

Week 3 sits at the very beginning of the Wegovy weight loss curve. Here is how it fits:

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Wegovy Results After 3 Weeks: What to Expect
PhaseWeeksDoseExpected Loss
Introduction (you're here)1-40.25 mg0.5-2%
Early escalation5-80.5 mg2-4%
Mid escalation9-121.0 mg4-7%
Late escalation13-161.7 mg6-9%
Maintenance17+2.4 mg9-15%+

The most rapid weight loss occurs during the maintenance phase at 2.4 mg. Everything you're doing now is building toward that period. For a complete cost breakdown, see our cheapest semaglutide options.

The 0.5 mg Transition: What to Know

Next week brings your first dose increase. The jump from 0.25 mg to 0.5 mg is a 100% dose increase, the largest proportional increase in the Wegovy escalation schedule. Here is what to expect:

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →
  • Appetite: Noticeably stronger suppression within 2-3 days of the first 0.5 mg injection
  • Nausea: May return briefly in about 20-30% of patients. Usually milder and shorter than the initial 0.25 mg nausea
  • Weight loss: Should pick up to 0.5-1 lb per week or more
  • Meal size: Many patients find their meal portions drop by 30-50% compared to pre-treatment

Frequently Asked Questions

I have only lost 1 pound in 3 weeks. Is Wegovy working?

Yes. At 0.25 mg, 1 pound of weight loss is within the expected range. The medication is active in your body even if the scale is barely moving. Significant weight loss starts at 0.5 mg and accelerates through the higher doses.

Can I request a faster escalation schedule?

Some providers are flexible about shortening the 0.25 mg phase to 2-3 weeks if tolerability is excellent. But the standard 4-week protocol provides the smoothest transition. Discuss your preferences with your provider. Wegovy dose schedule

Should I be worried about hair loss?

Hair thinning can occur with significant weight loss (not specifically from semaglutide). It's usually temporary and related to caloric deficit and nutritional changes. Ensuring adequate protein (80-100g daily), iron, zinc, and biotin can minimize this risk. Hair loss typically occurs months into treatment, not at week 3.

Is week 3 a good time to get blood work done?

If you did not get baseline labs before starting, get them now. Otherwise, plan for your first follow-up labs at week 12 (after 8 weeks at the 0.5 mg dose). This timing captures meaningful metabolic changes.

One More Week

You have almost completed the introductory phase. Week 4 is your final week at 0.25 mg. Use it to lock in your habits, prepare your kitchen and meal plans, and get mentally ready for the step up. The 0.5 mg dose is where Wegovy starts to feel like a genuine weight loss tool.

At FormBlends, we prepare patients for each dose transition with specific guidance tailored to their experience so far.

Approaching your first increase? Connect with us for personalized transition support.

See your options in about 2 minutes

Take the free quiz and see what fits you. Quick, private, and no commitment to continue.

See my options →
Wegovy Results After 3 Weeks: What to Expect custom 2026 header image for GLP-1 Weight Loss
Custom header image for Wegovy Results After 3 Weeks: What to Expect, GLP-1 Weight Loss, and better treatment decision-making.

Research Snapshot

Medication guide
Page type
Medication guide
Page metadata
Page updated
2026-04-01
Page metadata
FormBlends official source
Official source
Retatrutide official website
Official source
Semaglutide official website
Official source
Tirzepatide official website
Official source
Wegovy official website
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Page updated: 2026-04-01.

Continue with decision-grade research

Compare the options behind this question

These pages separate verified facts, commercial terms, and unresolved claims so you can check the evidence before choosing a provider.

GLP-1 decision path

Use this page to decide if a provider review is the right next step

Related treatment context

Wegovy Results After 3 Weeks: What to Expect research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.

Evidence check

The strongest GLP-1 pages connect the practical answer to clinical trials, FDA labeling where applicable, and real access constraints.

Safety check

A licensed clinician still needs to review health history, contraindications, current medications, side effects, and dose escalation.

Next step

When the page matches your goal, continue into the FormBlends get-started flow so the intake can route you toward the right prescription review path.

FormBlends Editorial Context

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use FormBlends tools and data

Compare provider prices, explore local access and check calculations using FormBlends tools and data.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by FormBlends Editorial Research

Prepared by FormBlends Editorial Research.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded semaglutide first month $99, then $190 per month, shipping included.

Next Best Reads

FormBlends for iPhone

Shot days, doses and progress in one place

The free FormBlends iPhone app tracks GLP-1 doses, shot-day reminders, weight trends, meals and private progress photos.

Free Tools

Calculators to support your weight loss journey.